Wikipedia:Version 1.0 Editorial Team/Pharmacology articles by quality log
Appearance
![]() | This is a log of operations by a bot. The contents of this page are unlikely to need human editing. In particular, links should not be disambiguated as this is a historical record. |
July 29, 2025
[edit]Renamed
[edit]- AM-2-19 renamed to Turletricin.
Reassessed
[edit]- 177 Lu-NNS309 (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t)
- 1cP-MIPLA (talk) reassessed. Quality rating changed from Unassessed-Class to Stub-Class. (rev · t) Importance rating changed from Unknown-Class to Low-Class. (rev · t)
- 2,3,4,6-Tetramethoxyamphetamine (talk) reassessed. Quality rating changed from Unassessed-Class to Stub-Class. (rev · t) Importance rating changed from Unknown-Class to Low-Class. (rev · t)
- 2,3,4,6-Tetramethoxyphenethylamine (talk) reassessed. Quality rating changed from Unassessed-Class to Stub-Class. (rev · t) Importance rating changed from Unknown-Class to Low-Class. (rev · t)
- 2,3,5,6-Tetramethoxyphenethylamine (talk) reassessed. Quality rating changed from Unassessed-Class to Stub-Class. (rev · t) Importance rating changed from Unknown-Class to Low-Class. (rev · t)
- 2,4,6-Trimethoxyphenethylamine (talk) reassessed. Quality rating changed from Unassessed-Class to Start-Class. (rev · t) Importance rating changed from Unknown-Class to Low-Class. (rev · t)
- Cipargamin (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t)
- Divarasib (talk) reassessed. Quality rating changed from Stub-Class to C-Class. (rev · t)
- Luxdegalutamide (talk) reassessed. Quality rating changed from Stub-Class to C-Class. (rev · t)
- Mosunetuzumab (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t)
- Obinutuzumab (talk) reassessed. Quality rating changed from Stub-Class to C-Class. (rev · t)
- PNU-22394 (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
Assessed
[edit]- 2CBecca (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- Category:Androgens (talk) assessed. Quality assessed as Category-Class. (rev · t) Importance assessed as NA-Class. (rev · t)
- F (psychedelic) (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- Fenebrutinib (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- Nivegacetor (talk) assessed. Quality assessed as C-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- Turletricin (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
- Votoplam (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
Removed
[edit]- Category:Anabolic–androgenic steroids (talk) removed.
July 28, 2025
[edit]Renamed
[edit]- ALTO-100 renamed to Amdiglurax.
- NBI-1117568 renamed to Direclidine.
- NNZ-2591 renamed to Ercanetide.
- NV-5138 renamed to Mefluleucine.
- RE-104 renamed to Luvesilocin.
- SP-624 renamed to Forvisirvat.
Reassessed
[edit]- 1F-LSD (talk) reassessed. Quality rating changed from Unassessed-Class to Stub-Class. (rev · t)
- Personal care products (talk) reassessed. Quality rating changed from Start-Class to C-Class. (rev · t)
Assessed
[edit]- 2C-T-9 (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
- Amdiglurax (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- BK-6-MAPB (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
- Bifikafusp alfa/onfekafusp alfa (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Mid-Class. (rev · t)
- Deudimethyltryptamine (talk) assessed. Quality assessed as List-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
- Direclidine (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
- Ercanetide (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- Forvisirvat (talk) assessed. Quality assessed as Stub-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
- IPLA (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
- L-Iso-LSD (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
- L-LSD (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
- Luvesilocin (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- Lysergic acid diethylamide (disambiguation) (talk) assessed. Quality assessed as List-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
- Mefluleucine (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- SPL028 (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
- Zervimesine (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
July 27, 2025
[edit]Reassessed
[edit]- 2C-B-5-hemiFLY-α6 (talk) reassessed. Quality rating changed from Unassessed-Class to Start-Class. (rev · t)
Assessed
[edit]- 1F-LSD (talk) assessed. Importance assessed as Unknown-Class. (rev · t)
- 3,4,5-Trimethoxytranylcypromine (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
- 4-AcO-MALT (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
- DIPLA (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
- List of cannabinoids (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
- List of entactogens (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
- List of hallucinogens (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
- MAL-LAD (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
July 26, 2025
[edit]Reassessed
[edit]- 2-Oxo-3-hydroxy-LSD (talk) reassessed. Quality rating changed from Unassessed-Class to Stub-Class. (rev · t)
- Lovotibeglogene autotemcel (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
Removed
[edit]July 25, 2025
[edit]Renamed
[edit]- Lewis B. Sheiner renamed to Lewis B. Sheiner.
Reassessed
[edit]- 2,5-Dimethoxy-4-isobutylamphetamine (talk) reassessed. Quality rating changed from Start-Class to Stub-Class. (rev · t)
- Seeding trial (talk) reassessed. Quality rating changed from B-Class to C-Class. (rev · t)
Assessed
[edit]- Naminidil (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
- P-1075 (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
July 24, 2025
[edit]Reassessed
[edit]- Addiction (talk) reassessed. Quality rating changed from B-Class to C-Class. (rev · t)
- Masitinib (talk) reassessed. Quality rating changed from Stub-Class to Start-Class. (rev · t)
July 23, 2025
[edit]Assessed
[edit]- NeoGenomics (talk) assessed. Quality assessed as Start-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- Draft:Royal Honey (talk) assessed. Importance assessed as NA-Class. (rev · t)